At a glance
ClinicalIndex Comparison RecordN/ACompleted· 450 target
Drug / intervention
Gene mutation sampleprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
In Brief
An observational study evaluating Gene mutation sample for Hyperbilirubinemia and Jaundice. Completed, enrolled 450 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the demographic, metabolic, and genomic characteristics of patients who develop severe hyperbilirubinemia to patients who never developed a significant bilirubin level.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHyperbilirubinemia, Jaundice
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2006
First PostedOct 2006
Primary CompletionDec 2007
TodayJul 2026
First PostedOct 3, 2006
Enrollment StartSep 1, 2006
Primary CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 19.7 years ago
Interventions
Gene mutation sampleprocedure